NCT04353401View on ClinicalTrials.gov

WGS Analysis of COVID-19 Positive Patients

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Coronavirus InfectionCOVID-19
Trial Locations (1)

44106

Vanda Investigational Site, Cleveland

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY